etuvetidigene autotemcel
| Brand name | waskyra |
|---|---|
| Active ingredient | etuvetidigene autotemcel |
| Strength | 1.9-11.4x10^6CD34+ CELLS/ML |
| Dosage form | Solution |
| Route | Intravenous |
| Modality | Biologic |
| FDA approval | December 2025 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.